BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1593688)

  • 1. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer.
    Petros JA; Catalona WJ
    J Urol; 1992 Jun; 147(6):1574-5. PubMed ID: 1593688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Staging pelvic lymphadenectomy for carcinoma of the prostate].
    Rinsho K; Ishikawa S; Nemoto R; Koiso K; Takeshima H; Uchida K
    Hinyokika Kiyo; 1985 Sep; 31(9):1583-7. PubMed ID: 4083215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
    Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
    Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications for pelvic lymphadenectomy in clinically localized prostate cancer].
    Peneau M; Villers A; Molinié V; Theis D; Soulié M
    Prog Urol; 2004 Jun; 14(3):287-94. PubMed ID: 15373168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features of unsuspected regional lymph node metastases in prostatic adenocarcinoma.
    Saltzstein SL; McLaughlin AP
    Cancer; 1977 Sep; 40(3):1212-21. PubMed ID: 902239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of lymph node metastasis and its impact on long-term prognosis in clinically localized prostate cancer.
    Arai Y; Kanamaru H; Yoshimura K; Okubo K; Kamoto T; Yoshida O
    Int J Urol; 1998 Sep; 5(5):459-65. PubMed ID: 9781435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of and indications for pelvic lymph node dissection in the staging of prostate cancer.
    Middleton RG
    NCI Monogr; 1988; (7):41-3. PubMed ID: 3173502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical prostatectomy for stage B2 prostatic cancer.
    Middleton RG; Smith JA
    J Urol; 1982 Apr; 127(4):702-3. PubMed ID: 7069834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases.
    McLaughlin AP; Saltzstein SL; McCullough DL; Gittes RF
    J Urol; 1976 Jan; 115(1):89-94. PubMed ID: 1246119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series.
    Godoy G; von Bodman C; Chade DC; Dillioglugil O; Eastham JA; Fine SW; Scardino PT; Laudone VP
    J Urol; 2012 Jun; 187(6):2082-6. PubMed ID: 22498221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laparoscopic pelvic lymphadenectomy in prostate cancer].
    Hattori R; Kinukawa T; Ono Y; Kato N; Sahashi M; Yamada S; Mizutani K; Fujita T; Matsuura O; Ohshima S
    Nihon Hinyokika Gakkai Zasshi; 1994 Dec; 85(12):1729-33. PubMed ID: 7869646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inguinal hernia after radical retropubic prostatectomy for prostate cancer: a study of incidence and risk factors in comparison to no operation and lymphadenectomy.
    Lodding P; Bergdahl C; Nyberg M; Pileblad E; Stranne J; Hugosson J
    J Urol; 2001 Sep; 166(3):964-7. PubMed ID: 11490256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in pathological characteristics and prognosis of clinical A2 prostatic cancer from A1 and B disease.
    Golimbu M; Schinella R; Morales P; Kurusu S
    J Urol; 1978 May; 119(5):618-22. PubMed ID: 660732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-stage laparoscopic pelvic lymphadenectomy and radical perineal prostatectomy.
    Thomas R; Steele R; Smith R; Brannan W
    J Urol; 1994 Oct; 152(4):1174-7. PubMed ID: 8072087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy.
    Heidenreich A; Pfister D; Thüer D; Brehmer B
    BJU Int; 2011 Jan; 107(2):220-5. PubMed ID: 20590538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.